-
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxychroman-4-one
-
BD6266644049-38-197%
-
¥1167.05mg
-
Seractide
-
BD11262912279-41-399%
-
¥1072.025mg
-
(4S,7S,10S,13S,16S,22S)-7-((1H-Imidazol-4-yl)methyl)-16-((1H-indol-3-yl)methyl)-26-amino-22-((S)-2-(((S)-1-amino-3-methyl-1-oxobutan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-10-benzyl-13-(3-guanidinopropyl)-4-((2S,5S,8S,11S)-8-(4-hydroxybenzyl)-5,11-bis(hydroxymethyl)-2-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanamido)-5,8,11,14,17,20-hexaoxo-6,9,12,15,18,21-hexaazahexacosanoic acid
-
BD113558581-05-599%
-
¥6996.0100mg
-
(4S,5R)-4,5-Dihydroxy-3-((E)-prop-1-en-1-yl)cyclopent-2-enone
-
BD00785955582-46-795% mix TBC as stabilizer
-
¥4851.010mg
-
Snt-207707
-
BD007818101064662-40-398%
-
¥
-
L-Valinamide, N-acetyl-L-seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-xTFA salt
-
BD01126550171869-93-598%
-
¥6580.0100mg
-
(R)-N-((R)-1-(4-((1H-1,2,4-Triazol-1-yl)methyl)-4-cyclohexylpiperidin-1-yl)-3-(4-chlorophenyl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
-
BD01105138312637-48-298%
-
¥928.010mg
-
(5Z,11E)-7,8,9,16-Tetrahydroxy-14-methoxy-3-methyl-3,4,7,8,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecin-1-one
-
BD0115222166018-41-597%
-
¥
-
2-[2-[2-(5-Bromo-2-methoxyphenyl)ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole, monohydrochloride
-
BD012578461706524-94-898%
-
¥
-
Resomelagon
-
BD015561651809420-71-098%
-
¥
-
MSG606 TFA
-
BD0184047898%
-
¥
-
MPCI
-
BD01867996884538-31-298%
-
¥
-
PG106 TFA
-
BD0187887298%
-
¥
-
2-(3-(1-(2-Nitrophenyl)-1H-pyrrol-2-yl)allylidene)hydrazine-1-carboximidamide acetate
-
BD01887546959850-74-998%
-
¥1950.010mg
-
Resomelagon acetate
-
BD021274801809420-72-198%
-
¥
-
IIIM-8
-
BD023396961128053-62-298%
-
¥
-
Bivamelagon hydrochloride
-
BD023360032641595-55-198%
-
¥
-
Tetrapeptide-1
-
BD023495141632354-04-198%
-
¥
-
N,N′-Diferuloylputrescine
-
BD0234653242369-86-898%
-
¥
-
TCMCB07
-
BD023654991456699-27-698%
-
¥